Tumor suppressor genes: the puzzle and the promise.
Tumor suppressor genes are wild-type alleles of genes that play regulatory roles in cell proliferation, differentiation, and other cellular and systemic processes. It is their loss or inactivation that is oncogenic. The first evidence of tumor suppressor genes appeared in the early 1970s, but only within the past few years has a wealth of new information illuminated the central importance of these genes. Two or more different suppressor genes may be inactivated in the same tumors, and the same suppressors may be inactive in different tumor types (for example, lung, breast, and colon). The suppressor genes already identified are involved in cell cycle control, signal transduction, angiogenesis, and development, indicating that they contribute to a broad array of normal and tumor-related functions. It is proposed that tumor suppressor genes provide a vast untapped resource for anticancer therapy.
Sager
R
R
Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA.
D000483:Alleles; D000818:Animals; D002454:Cell Differentiation; D002455:Cell Division; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D002869:Chromosome Aberrations; D003001:Cloning, Molecular; D005134:Eye Neoplasms / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D006822:Hybrid Cells; D007680:Kidney Neoplasms / Q000235:genetics; D009154:Mutation; D009369:Neoplasms / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics; D010750:Phosphoproteins / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length; D012175:Retinoblastoma / Q000235:genetics; D013489:Suppression, Genetic / Q000235:genetics*; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53; D009396:Wilms Tumor / Q000235:genetics
D015513:Oncogene Proteins; D010750:Phosphoproteins; D016159:Tumor Suppressor Protein p53